Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB1 Cervical Cancer FIGO 2018”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07617818
What this trial is testing

QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer

Who this might be right for
Cervical CancerNeoadjuvant TherapyImmunotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Not applicableActive Not RecruitingNCT04574635
What this trial is testing

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Who this might be right for
Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more
Mayo Clinic 18
Not applicableWithdrawnNCT05093712
What this trial is testing

Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy

Who this might be right for
Stage IB Cervical Cancer FIGO 2018Stage IB1 Cervical Cancer FIGO 2018Stage IB2 Cervical Cancer FIGO 2018+13 more
M.D. Anderson Cancer Center